WallStreetZenWallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan BillerEVP and Chief Legal Officer2025-10-02694$404.21
$280.52kSell
Jonathan BillerEVP and Chief Legal Officer2025-10-011,259$400.00
$503.60kSell
Sangeeta N. BhatiaDirector2025-08-27266$386.69
$102.86kSell
Reshma KewalramaniCEO President2025-08-065,710$389.95
$2.23MBuy
Reshma KewalramaniCEO President2025-08-064,290$389.08
$1.67MBuy
Bruce I. SachsDirector2025-08-063,366$389.84
$1.31MBuy
Bruce I. SachsDirector2025-08-061,634$389.36
$636.21kBuy
Stuart A. ArbuckleEVP COO2025-07-0137,243$450.23
$16.77MSell
David AltshulerEVP Chief Scientific Officer2025-05-1552$424.69
$22.08kSell
Sangeeta N. BhatiaDirector2025-05-02400$505.86
$202.34kSell

1 of 8

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Capital World Investors11.21%28,732,143$12.14BInstitution
Vanguard Group Inc9.35%23,973,777$10.13BInstitution
Blackrock Inc8.53%21,871,945$9.24BInstitution
Capital Research Global Investors6.28%16,108,291$6.81BInstitution
State Street Corp4.59%11,775,227$4.98BInstitution
Fmr LLC2.50%6,406,372$2.71BInstitution
Jennison Associates LLC2.40%6,151,505$2.60BInstitution
Geode Capital Management LLC2.31%5,928,747$2.51BInstitution
Jpmorgan Chase Co2.29%5,869,361$2.48BInstitution
Wellington Management Group LLP1.88%4,813,386$2.03BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX93.79%1.50%Net SellingNet Buying
REGN68.94%31.06%Net Selling
ALNY82.79%17.21%Net SellingNet Selling
ARGX52.63%0.00%
ONC2.41%32.39%Net SellingNet Selling
View Top Biotech Stocks

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 93.79% institutional shareholders, 1.50% Vertex Pharmaceuticals insiders, and 4.71% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 28.73M shares representing 11.21% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $12.11B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.